APA (7th ed.) Citation

Emily P. Mihalko, Kimberly Nellenbach, Manasi Krishnakumar, Nina Moiseiwitsch, Jennifer Sollinger, Brian C. Cooley, & Ashley C. Brown. (2022). Fibrin‐specific poly(N‐isopropylacrylamide) nanogels for targeted delivery of tissue‐type plasminogen activator to treat thrombotic complications are well tolerated in vivo. Wiley.

Chicago Style (17th ed.) Citation

Emily P. Mihalko, Kimberly Nellenbach, Manasi Krishnakumar, Nina Moiseiwitsch, Jennifer Sollinger, Brian C. Cooley, and Ashley C. Brown. Fibrin‐specific Poly(N‐isopropylacrylamide) Nanogels for Targeted Delivery of Tissue‐type Plasminogen Activator to Treat Thrombotic Complications Are Well Tolerated in Vivo. Wiley, 2022.

MLA (9th ed.) Citation

Emily P. Mihalko, et al. Fibrin‐specific Poly(N‐isopropylacrylamide) Nanogels for Targeted Delivery of Tissue‐type Plasminogen Activator to Treat Thrombotic Complications Are Well Tolerated in Vivo. Wiley, 2022.